Septic shock during platelet transfusion in a patient with acute myeloid leukaemia

Julie Haesebaert1, Thomas Bénet, Mauricette Michallet

  • 1Department of Infection Control and Epidemiology Unit, Edouard Herriot Hospital, Lyon, France.

BMJ Case Reports
|November 1, 2013
PubMed

Insights

Transfusion-associated bacterial contamination (TABC) is a serious risk during platelet concentrate (PC) transfusions. This case highlights Escherichia coli sepsis from a contaminated PC unit, emphasizing immediate investigation and intervention.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Transfusion Medicine

Background:

  • Transfusion-associated bacterial contamination (TABC) poses the primary risk in platelet concentrate (PC) transfusions, with potential outcomes ranging from mild symptoms to fatal sepsis.
  • Platelet transfusions are critical for patients with hematological conditions like acute myeloid leukemia (AML).

Observation:

  • A patient with AML developed severe sepsis and septic shock rapidly after initiating a PC transfusion.
  • Blood and PC unit cultures identified identical isolates of Escherichia coli, with no other source detected.
  • Investigations into the donor and related blood products yielded negative results.

Findings:

  • The clinical presentation and microbiological evidence strongly suggest TABC as the cause of sepsis.
  • The identical E. coli strains in the patient and the PC unit confirm the link.
  • Establishing definitive causality can be challenging in TABC cases.

Implications:

  • Physicians must maintain a high index of suspicion for TABC in patients experiencing adverse reactions during PC transfusion.
  • Immediate cessation of transfusion and prompt diagnostic workup are crucial for managing suspected TABC.
  • Current practices lack methods to completely eliminate TABC risk, necessitating vigilance and preparedness.